Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Robert Bradway
Biotech
UPDATE: Amgen axes an obesity asset, zooms in on MariTide
Amgen is axing obesity candidate AMG 786 and going all in on later-stage asset MariTide.
Gabrielle Masson
May 2, 2024 6:16pm
Amgen teams up with Adaptive to both treat and prevent COVID-19
Apr 2, 2020 9:30am
As Amgen zeroes in on cancer, neuroscience pipeline under the ax
Oct 30, 2019 3:47am
Amgen's KRAS drug shows promise in 2 additional cancers
Jul 30, 2019 5:29pm
Chutes & Ladders—Allergan lures new CFO from Catalent
Feb 9, 2018 3:22am
